Microsoft and Causaly Partner to Speed Up Drug Discovery

A new collaboration between Microsoft and biotech company Causaly is bringing AI-powered scientific reasoning to drug discovery, potentially cutting research time from years to months.

The partnership announced June 4 could help scientists find new treatments faster by connecting millions of research papers with cutting-edge analytics.